Filter by content type
Filter by content year
Filter by form group
Filter by type
Filter by tags
Filter by gallery
Filter by category
Filter by category
Filter by category
Filter by category
Biogen Idec to Present at the 31st Annual J.P. Morgan Healthcare Conference
January 2, 2013 - … Biogen Idec to Present at the 31st Annual J.P. Morgan Healthcare Conference Biogen Idec to Present at the 31st Annual J.P. Morgan … Corporate General WESTON, Mass.--( BUSINESS WIRE )--Biogen Idec Inc. (NASDAQ: BIIB) announced today that it will … Biogen Idec to Present at the 31st Annual J.P. Morgan …
Biogen Idec Reports Top-Line Results from Phase 3 Trial Investigating Dexpramipexole in People with Amyotrophic Lateral Sclerosis (ALS)
January 3, 2013 - … Biogen Idec Reports Top-Line Results from Phase 3 Trial … in People with Amyotrophic Lateral Sclerosis (ALS) Biogen Idec Reports Top-Line Results from Phase 3 Trial … endpoints -- WESTON, Mass.--( BUSINESS WIRE )--Today Biogen Idec (NASDAQ: BIIB) reported top-line results of …
Biogen Idec Submits Application to FDA for First Long-Lasting Factor IX Therapy for Hemophilia B
January 4, 2013 - … Biogen Idec Submits Application to FDA for First Long-Lasting Factor IX Therapy for Hemophilia B Biogen Idec Submits Application to FDA for First Long-Lasting … 1-2 weeks -- WESTON, Mass.--( BUSINESS WIRE )--Today Biogen Idec (NASDAQ: BIIB) announced the company recently …
Biogen Idec to Report Fourth Quarter & Year End 2012 Financial Results on January 28, 2013
January 14, 2013 - … Biogen Idec to Report Fourth Quarter & Year End 2012 Financial Results on January 28, 2013 Biogen Idec to Report Fourth Quarter & Year End 2012 … Corporate General WESTON, Mass.--( BUSINESS WIRE )--Biogen Idec Inc. (NASDAQ: BIIB) today announced it will …
Biogen Idec and Elan Submit Applications for First-Line Use of TYSABRI in anti-JCV Antibody Negative Patients with MS
January 16, 2013 - … Biogen Idec and Elan Submit Applications for First-Line Use … of TYSABRI in anti-JCV Antibody Negative Patients with MS Biogen Idec and Elan Submit Applications for First-Line Use … Data - WESTON, Mass. & DUBLIN--( BUSINESS WIRE )--Today Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: …
Biogen Idec Announces Positive Top-Line Results from Phase 3 Study of Peginterferon Beta-1a in Multiple Sclerosis
January 24, 2013 - … Biogen Idec Announces Positive Top-Line Results from Phase 3 Study of Peginterferon Beta-1a in Multiple Sclerosis Biogen Idec Announces Positive Top-Line Results from Phase 3 … Submissions – WESTON, Mass.--( BUSINESS WIRE )--Today Biogen Idec (NASDAQ: BIIB) released the primary efficacy …
Biogen Idec 2012 Revenue Increases 9% to $5.5 Billion
January 28, 2013 - … Biogen Idec 2012 Revenue Increases 9% to $5.5 Billion Biogen Idec 2012 Revenue Increases 9% to $5.5 Billion January … capabilities of both companies’ Research Triangle Park (RTP)-based facilities. Under the terms of the agreement, … Biogen Idec 2012 Revenue Increases 9% to $5.5 Billion …
Biogen Idec to Acquire Full Rights and Control of TYSABRI® from Elan for Upfront Cash and Contingent Payments
February 6, 2013 - … Biogen Idec to Acquire Full Rights and Control of TYSABRI® … from Elan for Upfront Cash and Contingent Payments Biogen Idec to Acquire Full Rights and Control of TYSABRI® … February 6, 2013 Neurodegenerative Diseases General -- Biogen Idec gains all marketing, distribution and governance …
New Phase 3 Data Reinforce Long-Lasting Protection from Bleeding for Patients with Hemophilia A and B
February 8, 2013 - … standard of care – WARSAW, Poland--( BUSINESS WIRE )-- Biogen Idec (NASDAQ: BIIB) and Swedish Orphan Biovitrum … of Global Medical Affairs and chief medical officer of Biogen Idec’s hemophilia therapeutic area. “Less frequent … used in FDA-approved medicines for more than a decade. Biogen Idec and Swedish Orphan Biovitrum applied Fc fusion …
Cambridge Science Festival Announces Statewide Year-Round Science Outreach Initiative: Biogen Idec Foundation Science on the Street
February 15, 2013 - … Statewide Year-Round Science Outreach Initiative: Biogen Idec Foundation Science on the Street Cambridge … Statewide Year-Round Science Outreach Initiative: Biogen Idec Foundation Science on the Street February 15, … )--The Cambridge Science Festival (CSF) today announced “Biogen Idec Foundation Science on the Street,” a new …
